The historic rise of Viagra has long been a example of pharmaceutical success, however its future within the broader sector now raises questions about long-term yields . Copycat versions are eroding patent protection , causing worries that betting on companies heavily reliant to Viagra's previous influence could be a problematic strategy, especiall